Download This Report

Please complete the form below and we will email the report.

    Eliminating Protein Aggregates Linked to Immune Response A Revolutionary Syringe Technology for Biologic Therapeutics

    By Christopher Weikart, PhD, Chief Scientist, SIO2 Materials Science

    Therapeutic biologic drugs serve an omnipresent role in treating a wide range of diseases today. A growing body of literature, however, indicates that injectable biologic proteins can produce adverse drug reactions in both animals and humans….